Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes

Post Graduate Institute of Medical Education and Research, Chandigarh

Status: Unknown

Conditions: Type 2 Diabetes Mellitus

Treatments: Drug: Metformin; Drug: Gurmar

Study type: Interventional

Funder types: Other; NETWORK

Identifiers

NCT00396851

Pharma 6/700

Details and patient eligibility

About

The study plans to compare the glucose-lowering effect of gurmar, a herbal preparation, with metformin in patients with type 2 diabetes

Sex: All

Ages: 25 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Newly detected type 2 diabetes
• Fasting plasma glucose >126mg/dl
• HbA1c > 7%

Exclusion criteria

• Serious comorbid illnesss
• History of drug abuse
• History of recent weight loss

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind